91 related articles for article (PubMed ID: 3285797)
1. [Recent advances in L-asparaginase studies].
Taguchi T
Gan To Kagaku Ryoho; 1988 May; 15(5):1815-25. PubMed ID: 3285797
[TBL] [Abstract][Full Text] [Related]
2. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
Nesbit ME; Ertel I; Hammond GD
Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
[TBL] [Abstract][Full Text] [Related]
3. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
Nesbit M; Chard R; Evans A; Karon M; Hammond GD
Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
[TBL] [Abstract][Full Text] [Related]
5. Favorable remission induction rate with twice weekly doses of L-asparaginase.
Jaffe N; Traggis D; Das L; Frauenberger G; Hann HW; Kim BS; Bishop Y
Cancer Res; 1973 Jan; 33(1):1-4. PubMed ID: 4565907
[No Abstract] [Full Text] [Related]
6. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
[No Abstract] [Full Text] [Related]
7. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
[TBL] [Abstract][Full Text] [Related]
8. [Complete remission obtained in refractory acute lymphocytic leukemia using high-dose cytosine arabinoside combined with low-dose L-asparaginase].
Inagaki C; Ito K; Omori I; Shimazaki C; Nishio A; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Feb; 12(2):379-82. PubMed ID: 3855616
[TBL] [Abstract][Full Text] [Related]
9. [L-asparaginase in blast leukemia].
Georgiev Z; Genova V; Avramova D
Vutr Boles; 1973; 12(6):25-37. PubMed ID: 4522152
[No Abstract] [Full Text] [Related]
10. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
[No Abstract] [Full Text] [Related]
11. [Attempts at treatment of acute leukemia with L-asparaginase].
Lawkowicz W; Krzemińska-Lawkowiczowa ; Kozlowska J; Polubiec A; Derulska D; Kolakowska-Polubiec K; Litwin J; Rokicka R
Acta Haematol Pol; 1971; 2(4):305-10. PubMed ID: 5293225
[No Abstract] [Full Text] [Related]
12. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
[No Abstract] [Full Text] [Related]
13. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement.
Cheung NK; Chau IY; Coccia PF
Am J Pediatr Hematol Oncol; 1986; 8(2):99-104. PubMed ID: 3526939
[TBL] [Abstract][Full Text] [Related]
14. [Use of L-asparaginase in therapy with special reference to acute lymphatic leukemia].
Storti E; Fontana G
Minerva Med; 1972 Mar; 63(24):1445-56. PubMed ID: 4502507
[No Abstract] [Full Text] [Related]
15. [L-asparaginase study results (phase II of the clinical trials)].
Kondrat'eva NA; Kruglova GV; Lorie IuI; Koshel' IV; Kurmashov VI
Antibiotiki; 1980 Sep; 25(9):686-9. PubMed ID: 6998370
[TBL] [Abstract][Full Text] [Related]
16. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase--antileukemia agent.
Bukhari SZ; Yaqub M
J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
[TBL] [Abstract][Full Text] [Related]
18. [Comparative evaluation of the clinical effectiveness of 3 preparations of E. coli L-asparaginase].
Kondrat'eva NA
Antibiotiki; 1984 Jul; 29(7):527-31. PubMed ID: 6385831
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of succinylated Acinetobacter glutaminase-asparaginase in adult leukemia.
Warrell RP; Arlin ZA; Gee TS; Chou TC; Roberts J; Young CW
Cancer Treat Rep; 1982 Jul; 66(7):1479-85. PubMed ID: 7046929
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
Boos J
Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
